Noninvasive risk stratification for sudden death in asymptomatic patients with Wolff-Parkinson-White syndrome
John Novella, Ralph M DeBiasi1, Neil L Coplan
1Yale University School of Medicine, Division of Cardiology, New Haven, CT.
Abstract:
Sudden cardiac death (SCD) as the first clinical manifestation of Wolff-Parkinson-White (WPW) syndrome is a well-documented, although rare occurrence. The incidence of SCD in patients with WPW ranges from 0% to 0.39% annually. Controversy exists regarding risk stratification for patients with preexcitation on surface electrocardiogram (ECG), particularly in those who are asymptomatic. This article focuses on the role of risk stratification using exercise and pharmacologic testing in patients with WPW pattern on ECG.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Dysrhythmias V: Evaluating Dysrhythmias
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Dysrhythmias II: Classification of Tachyarrhythmias
Heart Failure IV: Classification and Diagnostic Evaluation


